Concepedia

Drew MacCannell

DM

Statistics

Publications

4

Citations

74

H-Index

4

Active since

2021

Affiliations

Biogen (United States)(Current)

St. Jude Children's Research Hospital

Università Cattolica del Sacro Cuore

Sydney Children's Hospital

University Hospital Bonn

Drew MacCannell is an author at Biogen (United States) specializing in clinical pharmacology, nusinersen therapy, and population pharmacokinetic-pharmacodynamic modeling.

Publications per year

2021–2022

4

Publications

4

Scientific rationale for a higher dose of nusinersen

Richard S. Finkel, Monique M. Ryan, Samuel Ignacio Pascual Pascual et al. · Annals of Clinical and Translational Neurology · 2022 · 29 citations · Full text

, , +16

Population pharmacokinetics-based recommendations for a single delayed or missed dose of nusinersen

Drew MacCannell, Zdenek Berger, Lilly East et al. · Neuromuscular Disorders · 2021 · 23 citations · Full text

, , +16

Restoration of Nusinersen Levels Following Treatment Interruption in People With Spinal Muscular Atrophy: Simulations Based on a Population Pharmacokinetic Model

Drew MacCannell, Zdenek Berger, Janbernd Kirschner et al. · CNS Drugs · 2022 · 12 citations · Full text

, , +11

A pediatric quantitative systems pharmacology model of neurofilament trafficking in spinal muscular atrophy treated with the antisense oligonucleotide nusinersen

Alessio Paris, Pranami Bora, Silvia Parolo et al. · CPT Pharmacometrics & Systems Pharmacology · 2022 · 10 citations · Full text

, , +17

1–4 of 4